|Place of Origin:||China|
|Certification:||COA, HPLC MR|
|Model Number:||HBY-Amphotericin B|
|Minimum Order Quantity:||1KG|
|Packaging Details:||Aluminum Bag or 25KG/Fibre Drum|
|Delivery Time:||3-5 work days after your payment|
|Payment Terms:||Western Union, T/T, MoneyGram|
|Name:||99% Veterinary Drug Antifungal Pharmaceutical Raw Powder Amphotericin B||CAS:||1397-89-3|
|Molecular Weight:||924.079||Molecular Formula:||C47H73NO17|
|Shelf Life:||2 YEARS||Storage:||−20°c|
99% Amphotericin B Powder,
Yellow Amphotericin B Powder,
Veterinary fungal infection powder
What is 99% Veterinary Drug Antifungal Pharmaceutical Raw Powder Amphotericin B?
|Product Name||99% Veterinary Drug Antifungal Pharmaceutical Raw Powder Amphotericin B|
|Deliver Time||Within 24 Hours After Receiving The Payment|
Amphotericin B is a polyene antifungal agent with activity in vitro against a wide variety of fungal pathogens. Amphotericin B exerts its antifungal effect by disruption of fungal cell wall synthesis because of its ability to bind to sterols, primarily ergosterol, which leads to the formation of pores that allow leakage of cellular components. This affinity may also account for its toxic effects against select mammalian cells. Amphotericin B is generally considered cidal against susceptible fungi at clinically relevant concentrations.
Despite the introduction of newer antifungal agents for the treatment of systemic mycoses, amphotericin B remains the standard treatment for many severe, invasive fungal infections. However, because of toxicities associated with its intravenous use, along with the expanded availability of safer treatment options, it is frequently reserved for patients who have severe, life-threatening invasive fungal infections or who are unable to tolerate alternative antifungal agents. With the exception of neonatal candidiasis and treatment of Candida urinary tract infections, lipid-based formulations (most notably liposomal amphotericin B) have largely replaced amphotericin B deoxycholate due to their improved tolerability
One of the main uses of amphotericin B is treating a wide range of systemic fungal infections. Due to its extensive side effects, it is often reserved for severe infections in critically ill, or immunocompromised patients. It is considered first line therapy for invasive mucormycosis infections, cryptococcal meningitis, and certain aspergillus and candidal infections. It has been a highly effective drug for over fifty years in large part because it has a low incidence of drug resistance in the pathogens it treats. This is because amphotericin B resistance requires sacrifices on the part of the pathogen that make it susceptible to the host environment, and too weak to cause infection.
Amphotericin B is used for life-threatening protozoan infections such as visceral leishmaniasis and primary amoebic meningoencephalitis.
Package and Shipping of 99% Veterinary Drug Antifungal Pharmaceutical Raw Powder Amphotericin B